Although the adolescent and young adult cancer burden incidence is highest in the most developed settings, transitioning countries have the poorest outcomes and will face the greatest increases in burden by 2050. These findings act as a reference to the global adolescent and young adult cancer community to inform cancer control priorities and decrease global inequities.
Sex and gender play a fundamental a role in health and illness, influencing the conditions and symptoms a person develops, the effectiveness of treatments and…
Alan Percy, MD, discusses long-term data from clinical trial extension of trofinetide in patients with Rett syndrome.
To celebrate Native American Heritage Month, we spoke with Karina Walters, Ph.D., M.S.W., Director of the NIH Tribal Research Health Office (THRO). Dr. Walters, an…
Roy S. Herbst, MD, PhD, discusses advances in EGFR inhibition throughout the past several decades in patients with lung cancer.
Although HbA1c testing remains the gold standard for glucose monitoring in type 1 and type 2 diabetes, limitations include its inability to provide data around…
These CGM data support the long-term efficacy and safety of icodec versus glargine U100 during treatment and indicated no increase in the duration of individual…
In this studio-based webinar, a multidisciplinary expert panel will address the new treatment landscape of metastatic UCa via interactive case discussions on managing AEs and…
Earlier this year, Jarno Habicht, the WHO Representative in Ukraine, described the situation there as a “humanitarian crisis of unprecedented scale”. He noted that a…
Oxford University Press (OUP) invites applications for the position of Deputy Editor for The Oncologist. There are two Deputy Editor positions available, each
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid…
